PROM-Q: Comparison of Patient Reported Outcome Measures Using the BREAST-Q Questionnaire in Patients Undergoing Pre Versus Sub-pectoral Implant Based Immediate Breast Reconstruction.

Sponsor
The Leeds Teaching Hospitals NHS Trust (Other)
Overall Status
Recruiting
CT.gov ID
NCT04842240
Collaborator
(none)
60
1
39
1.5

Study Details

Study Description

Brief Summary

The PROM Q study aims to compare patient reported outcome measures (PROMs) in patients undergoing mastectomy and immediate implant based breast reconstruction (IBR). This is the commonest form of breast reconstruction and current advances in surgical technology have led to increasing number of patients having implants placed above the pectoral muscle (pre-pectoral), rather than below it (sub-pectoral). This has important benefits for patients including shorter surgery time, quicker recovery, and avoidance of animation deformity (visible muscle twitching of the reconstructed breast) as the pectoral muscle is not divided to cover the implant. However, potential disadvantages include rippling effect as the implant is covered by the skin and subcutaneous tissue only, as well as potentially higher risk of capsule (scar tissue) formation.

By utilising a validated questionnaire (BREAST-Q), we will assess for any difference in PROMs between the two groups of patients. The results will provide valuable information for future patients when making an informed decision about their reconstruction options. This questionnaire study will include consecutive patients undergoing mastectomy and immediate IBR for breast cancer as well as for risk reduction at Leeds Teaching Hospitals NHS Trust. The study participants will undergo either pre- or sub-pectoral IBR based on their informed discussion with the clinical team. This is a non-randomised observational study.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Pre- or sub-pectoral implant based immediate breast reconstruction

Detailed Description

Patients who undergo implant based immediate breast reconstruction (IBR) are offered an option of pre- versus sub-pectoral breast reconstruction. Both approaches are well established and have proven safety in terms of low rate of complication rates. However, we do not know if there is a significant difference in patient reported outcome measures (PROMs) between the two surgical techniques over time.

The study aims to investigate if the difference in the surgical technique for immediate implant breast reconstruction (pre- versus sub-pectoral) influences patient perceived outcomes. This is a prospective non-randomised longitudinal cohort study which will aim to recruit consecutive eligible patients undergoing mastectomy with immediate implant based reconstruction surgery for early breast cancer or risk reduction using repeated measures and mixed methods.

This study will utilise a well validated patient questionnaire for breast reconstruction (BREAST-Q; http://qportfolio.org/breast-q/breast-cancer/) and will be carried out at a teaching hospital breast unit. The specific objectives will be to compare aesthetic outcome, post-operative pain and functionality as reported by PROMs. The study participants will be followed up for 12 months. The PROMs data will be collected at baseline, 2 weeks, as well as at 3 and 12 months post-surgery. Matching data will be collected for each study participant including the type of surgery performed, patient characteristics, post-operative complications, and any recommended adjuvant treatment. These data will be correlated with the matching questionnaire results in order to explore for potential clinical factors which may influence PROMs.

Study Design

Study Type:
Observational
Anticipated Enrollment :
60 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Comparison of Patient Reported Outcome Measures in Patients Undergoing Pre Versus Sub-pectoral Implant Based Breast Reconstruction
Actual Study Start Date :
Sep 1, 2019
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Patients undergoing implant based immediate breast reconstruction.

Patients will undergo either pre- or sub-pectoral implant based immediate breast reconstruction.

Procedure: Pre- or sub-pectoral implant based immediate breast reconstruction
All study participants will undergo skin sparing mastectomy (with or without nipple preservation) for breast cancer or for risk reduction. Patients will undergo immediate breast reconstruction using an implant or a tissue expander. The device will be placed in pre- or sub-pectoral plane which will be supported by mesh (Tiloop/Surgimend Acellular Dermal Matrix) and/or a dermal flap.

Outcome Measures

Primary Outcome Measures

  1. To compare any difference in patient reported outcome measures in patients undergoing pre- versus sub-pectoral implant based breast reconstruction. [Up to 12 months post-surgery]

    To measure the difference in BREAST-Q score in patients undergoing pre- versus sub-pectoral implant based breast reconstruction. We will compare psychosocial well-being, satisfaction with breasts, physical well-being, animation deformity, and patient experience with the clinical team.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Skin or nipple sparing mastectomy with immediate implant based reconstruction for breast cancer or for risk reduction

  • Unilateral or bilateral mastectomy

  • Implant or expander based immediate reconstruction

  • Able to read and understand questionnaire in English

Exclusion Criteria:
  • Male or transgender

  • Mastectomy only with no reconstruction

  • Delayed reconstruction

  • Autologous reconstruction

  • Cognitive impairment or inability to provide informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Leeds Teaching Hospitals NHS Trust Leeds West Yorkshire United Kingdom LS9 7TF

Sponsors and Collaborators

  • The Leeds Teaching Hospitals NHS Trust

Investigators

  • Principal Investigator: Baek Kim, FRCS MD MA, Leeds Teaching Hospitals NHS Trust

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
The Leeds Teaching Hospitals NHS Trust
ClinicalTrials.gov Identifier:
NCT04842240
Other Study ID Numbers:
  • IRAS 283017
First Posted:
Apr 13, 2021
Last Update Posted:
Apr 13, 2021
Last Verified:
Apr 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by The Leeds Teaching Hospitals NHS Trust
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 13, 2021